Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test
2021
Abstract Due to an increasing number of dementia patients, the development of a rapid and sensitive method for cognitive assessment is awaited. Here, we examined the usefulness of a novel and short (3 min) eye tracking device to evaluate the cognitive function of normal control (NC, n = 52), mild cognitive impairment (MCI, n = 52), and Alzheimer's disease (AD, n = 70) subjects. Eye tracking total score declined significantly in MCI (**p
Keywords:
-
Correction
-
Source
-
Cite
-
Save
25
References
1
Citations
NaN
KQI